2003 Vol.21, N°5 - Suppl.31 - Table of contents

Early arthritis

Guest Editors: T. Pincus, J.S. Smolen

Full Papers

CER2115
2003,21,5,Suppl.31
Pg. 0001

Free to view

Introduction
T. Pincus, J.S. Smolen

CER2116
2003,21,5,Suppl.31
Pg. 0002-0004

Free to view

Cases of early inflammatory polyarthritis should not be classified as having rheumatoid arthritis
D.P.M. Symmons, J.M.W. Hazes, A.J. Silman

CER2117
2003,21,5,Suppl.31
Pg. 0005-0014

Free to view

A historical perspective concerning population-based and clinical studies of early arthritis and early rheumatoid arthritis
T. Sokka, T. Pincus

CER2118
2003,21,5,Suppl.31
Pg. 0015-0019

Free to view

Diagnosing early rheumatoid arthritis (RA). What are the problems and opportunities ?
H.R. Schumacher, F. Pessler, L.X. Chen

CER2119
2003,21,5,Suppl.31
Pg. 0020-0027

Free to view

Joint damage and disability in rheumatoid arthritis: An updated systematic review
D.L. Scott, C. Smith, G. Kingsley

CER2120
2003,21,5,Suppl.31
Pg. 0028-0036

Free to view

The histopathology of early synovitis
C.A. Hitchon, H.S. El-Gabalawy

CER2121
2003,21,5,Suppl.31
Pg. 0037-0041

Free to view

Is radiographic progression a realistic outcome measure in clinical trials with early inflammatory arthritis ?
R. Landewé, D. van de Heijde

CER2122
2003,21,5,Suppl.31
Pg. 0042-0049

Free to view

The role of ultrasonography and magnetic resonance imaging in early rheumatoid arthritis
R.J. Wakefield, K.O. Kong, P.G. Conaghan, A.K. Brown, P.J. O’Connor, P. Emery

CER2123
2003,21,5,Suppl.31
Pg. 0050-0053

Free to view

The evaluation of bone damage in rheumatoid arthritis with magnetic resonance imaging
R. Goldbach-Mansky, V. Mahadevan, L. Yao2, P.E. Lipsky

CER2124
2003,21,5,Suppl.31
Pg. 0054-0058

Free to view

Biochemical markers of joint tissue turnover in early rheumatoid arthritis
P. Garnero, P. Geusens, R. Landewé

CER2125
2003,21,5,Suppl.31
Pg. 0059-0064

Free to view

Autoantibodies in early arthritis: Advances in diagnosis and prognostication
W. Hueber, P.J. Utz, W.H. Robinson

CER2126
2003,21,5,Suppl.31
Pg. 0065-0070

Free to view

Number of active joints, not diagnosis, is the primary determinant of function and performance in early synovitis
L.H. Gerber, G. Furst, C. Yarboro, H. El-Gabalawy

CER2127
2003,21,5,Suppl.31
Pg. 0071-0074

Free to view

Work disability in early rheumatoid arthritis
T. Sokka

CER2128
2003,21,5,Suppl.31
Pg. 0075-0078

Free to view

Early arthritis clinic: A USA perspective
J.J. Cush

CER2129
2003,21,5,Suppl.31
Pg. 0079-0088

Free to view

Uniform databases in early arthritis: Specific measures to complement classification criteria and indices of clinical change
T. Pincus, T. Sokka

CER2130
2003,21,5,Suppl.31
Pg. 0089-0093

Free to view

Early predictors of outcome in juvenile idiopathic arthritis
A. Ravelli, A. Martini

CER2131
2003,21,5,Suppl.31
Pg. 0094-0099

Free to view

The Norfolk Arthritis Register (NOAR)
D.P.M. Symmons, A.J. Silman

CER2132
2003,21,5,Suppl.31
Pg. 0100-0105

Free to view

The Leiden Early Arthritis Clinic
J. van Aken, J.H.M. van Bilsen, C.F. Allaart, T.W.J. Huizinga, F.C. Breedveld

CER2133
2003,21,5,Suppl.31
Pg. 0106-0112

Free to view

Early arthritis and rheumatoid arthritis in Germany
H. Zeidler, S. Merkesdal, J.L. Hülsemann

CER2134
2003,21,5,Suppl.31
Pg. 0113-0117

Free to view

The Austrian Early Arthritis Registry
K.P. Machold, V.P.K. Nell, T.A. Stamm, G. Eberl, G. Steiner, J.S. Smolen

CER2135
2003,21,5,Suppl.31
Pg. 0118-0122

Free to view

The Oslo experience with arthritis registries
T.K. Kvien, T. Uhlig

CER2136
2003,21,5,Suppl.31
Pg. 0123-0128

Free to view

The French early arthritis registry
B. Combe

CER2137
2003,21,5,Suppl.31
Pg. 0129-0132

Free to view

Aggressive rheumatoid arthritis registry in Italy. Characteristics of the early rheumatoid arthritis subtype among patients classified according to the ACR criteria
GIARA Registry Study Group

CER2138
2003,21,5,Suppl.31
Pg. 0133-0137

Free to view

Early rheumatoid arthritis in Finland
T. Sokka

CER2139
2003,21,5,Suppl.31
Pg. 0138-0145

Free to view

Early rheumatoid arthritis in African-Americans: The CLEAR Registry
S.L. Bridges Jr., L.B. Hughes, T.R. Mikuls, G. Howard, H.K. Tiwari, G.S. Alarcón, J.M. McNicholl and L.W. Moreland for the CLEAR Investigators

CER2140
2003,21,5,Suppl.31
Pg. 0146-0153

Free to view

Databases of patients with early rheumatoid arthritis in the USA
T. Sokka, J. Willoughby, Y. Yazici, T. Pincus

CER2141
2003,21,5,Suppl.31
Pg. 0154-0157

Free to view

Window of opportunity in early rheumatoid arthritis: Possibility of altering the disease process with early intervention
M.A. Quinn, P. Emery

CER2142
2003,21,5,Suppl.31
Pg. 0158-0164

Free to view

Disease-modifying anti-rheumatic drug therapy and structural damage in early rheumatoid arthritis
R.H. Mullan, B. Bresnihan

CER2143
2003,21,5,Suppl.31
Pg. 0165-0168

Free to view

The Utrecht experience with different treatment strategies in early rheumatoid arthritis
S.M.M. Verstappen, J.W.G. Jacobs, and J.W.J. Bijlsma on behalf of the Utrecht Rheumatoid Arthritis Cohort study group

CER2144
2003,21,5,Suppl.31
Pg. 0169-0173

Free to view

DMARD use in early rheumatoid arthritis. Lessons from observations in patients with established disease
D. Aletaha, J.S. Smolen

CER2145
2003,21,5,Suppl.31
Pg. 0174-0178

Free to view

Combination therapy in early rheumatoid arthritis
L. Gossec, M. Dougados

CER2146
2003,21,5,Suppl.31
Pg. 0179-0185

Free to view

Methotrexate as the "anchor drug" for the treatment of early rheumatoid arthritis
T. Pincus, Y. Yazici, T. Sokka, D. Aletaha, J.S. Smolen

CER2147
2003,21,5,Suppl.31
Pg. 0186-0190

Free to view

Low dose glucocorticoids in early rheumatoid arthritis
V. Strand, L.S. Simon

CER2148
2003,21,5,Suppl.31
Pg. 0191-0194

Free to view

Role of biologics in early arthritis
P. Emery, Y. Seto

CER2149
2003,21,5,Suppl.31
Pg. 0195-0197

Free to view

The Early Rheumatoid Arthritis (ERA) Trial comparing the efficacy and safety of etanercept and methotrexate
J.M. Bathon, M.C. Genovese

CER2150
2003,21,5,Suppl.31
Pg. 0198-0199

Free to view

Role of adalimumab in the treatment of early rheumatoid arthritis
E.C. Keystone, B. Haraoui, V.P. Bykerk

CER2151
2003,21,5,Suppl.31
Pg. 0200-0202

Free to view

Role of infliximab in the treatment of early rheumatoid arthritis
E.C. Keystone, B. Haraoui, V.P. Bykerk

CER2152
2003,21,5,Suppl.31
Pg. 0203-0208

Free to view

The safety of biologic agents in early rheumatoid arthritis
A. Kavanaugh, E.C. Keystone

CER2153
2003,21,5,Suppl.31
Pg. 0209-0210

Free to view

A proposed treatment algorithm for rheumatoid arthritis: Aggressive therapy, methotrexate, and quantitative measures
J.S. Smolen, T. Sokka, T. Pincus, F.C. Breedveld